Publications by authors named "S W Bonde"
Retraction notice to "Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy" [Int. J. Biol. Macromol. 245 (2023) 125529].
Int J Biol Macromol
January 2025
Key Points: The 2015 Kidney Disease Outcomes Quality Initiative Guideline Update increased the contribution of residual kidney function, shortening the time required for twice weekly hemodialysis. No study had yet assessed the feasibility of prescribing twice weekly hemodialysis according to the updated guideline. Twice weekly hemodialysis prescribed using the updated guideline maintained quality of life and controlled fluid gain, potassium, and uremic solutes.
View Article and Find Full Text PDFChitosan (CS) composite gels have emerged as promising materials with diverse applications in biomedicine. This review provides a concise overview of recent advancements and key aspects in the development of CS composite gels. The unique properties of CS, such as biocompatibility, biodegradability, and antimicrobial activity, make it an attractive candidate for gel-based composites.
View Article and Find Full Text PDFArticle Synopsis
- DNA origami is an advanced nanotechnology that allows for the creation of customizable 2D and 3D nanostructures, providing precise control over their size and shape.
- Recent developments enable DNA origami to be used in programmable nanomedicines that can target specific disease triggers, particularly in oncology, but with potential applications in cardiovascular diseases.
- The review focuses on the essential characteristics of DNA origami, its targeting and cellular uptake mechanisms, and its significant therapeutic potential in addressing complex health issues like cardiovascular disease.
After surgical excision of breast cancer, chemotherapy is recommended to eradicate any undiagnosed cancer cells and lower the likelihood of the cancer recurring. Curcumin and quercetin are two old flavonoid medicines used to treat breast cancer. Besides ambient popularity, they possess poor water solubility and poor bioavailability, limiting their usefulness.
View Article and Find Full Text PDF